Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous PBSCT with In Vivo Purging for AML
NCT00531583Phase 2Completed
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Mar 2001
- Primary completion
- Jun 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous peripheral blood stem cell in acute myeloid leukemia (AML), sponsored by King Faisal Specialist Hospital and Research Centre. Started Mar 2001; status: completed.
02
Drugs
autologous peripheral blood stem cell
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00531583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00531583.